(Q43313674)

19 November 2017

Two-year follow-up of Schistosoma mansoni infection and morbidity after treatment with different regimens of oxamniquine and praziquantel (English)

1 reference

19 November 2017

0 references

1 reference

Gryseels B

1

1 reference

PubMed ID

2514474

19 November 2017

Nkulikyinka L

series ordinal

2

1 reference

19 November 2017

1 March 1989

1 reference

Transactions of the Royal Society of Tropical Medicine and Hygiene

19 November 2017

1 reference

19 November 2017

83

1 reference

19 November 2017

2

1 reference

19 November 2017

219-228

1 reference

Regulation of parasite populations. A general theory of the epidemiology and control of parasitic infections

19 November 2017

1 reference

https://api.crossref.org/works/10.1016%2F0035-9203%2889%2990655-X

Immunity in human schistosomiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0035-9203%2889%2990655-X

Immunity after treatment of human schistosomiasis mansoni. I. Study design, pretreatment observations and the results of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0035-9203%2889%2990655-X

Immunity after treatment of human schistosomiasis mansoni. II. Identification of resistant individuals, and analysis of their immune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0035-9203%2889%2990655-X

The morbidity of schistosomiasis mansoni in Maniema (Zaire).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0035-9203%2889%2990655-X

Field trials of praziquantel and oxamniquine for the treatment of schistosomiasis mansoni in Burundi.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0035-9203%2889%2990655-X

Repeated mass treatment of schistosomiasis mansoni: experience in hyperendemic areas of Brazil. I. Parasitological effects and morbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0035-9203%2889%2990655-X

Cost-effectiveness of different ways of controlling intestinal schistosomiasis: a case study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0035-9203%2889%2990655-X

A quantitative analysis of the diagnostic value of diethylcarbamazine provocation in endemic Wuchereria bancrofti infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0035-9203%2889%2990655-X

A three year follow-up of chemotherapy with oxamniquine in a Brazilian community with endemic schistosomiasis mansoni

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0035-9203%2889%2990655-X

Regulation of the prevalence and intensity of schistosomiasis in man: immunology or ecology?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0035-9203%2889%2990655-X

Dynamics of Schistosoma haematobium infection in a Gambian community. III. Acquisition and loss of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0035-9203%2889%2990655-X

Resistance to reinfection after treatment of urinary schistosomiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0035-9203%2889%2990655-X

10.1016/0035-9203(89)90655-X

21 January 2018

Identifiers

DOI

1 reference

19 November 2017

1 reference

PubMed ID

2514474